Sevoflurane Vaporizer

Get a Price/Quote

MOQ : 1000 Bottles

Sevoflurane Vaporizer Specification

Pacakaging (Quantity Per Box)
250 ml

Origin of Medicine
India

Packaging Type
Bottle

Drug Type
Specific Drug

Physical Form
Liquid

Recommended For
to deliver accurate concentrations (typically 0% to 8%) of sevoflurane for anesthesia

Dosage
As Directed By Physician

Dosage Guidelines
As Directed By Physician

Suitable For
Adults

Storage Instructions
Store In a Cool & Dry Place

Sevoflurane Vaporizer Trade Information

Minimum Order Quantity
1000 Bottles

FOB Port
ALL INDIA

Payment Terms
Western Union, Paypal, Cash in Advance (CID), Cash Advance (CA)

Supply Ability
1000 Bottles Per Month

Delivery Time
2-3 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
50 ml, 250 ml

Main Export Market(s)
Western Europe, Australia, North America, South America, Eastern Europe, Middle East, Central America, Asia, Africa

Main Domestic Market
All India

Certifications
WHO,GMP,COA As per client requirement

About Sevoflurane Vaporizer

Sevoflurane (1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane; synonym, fluoromethyl hexafluoroisopropyl ether), is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.

It is one of the most commonly used volatile anesthetic agents, particularly for outpatient anesthesia, across all ages, as well as in veterinary medicine. Together with desflurane, sevoflurane is replacing isoflurane and halothane in modern anesthesiology. It is often administered in a mixture of nitrous oxide and oxygen.

Sevoflurane has an excellent safety record, but is under review for potential neurotoxicity, especially relevant to administration in infants and children, and rare reports similar to halothane hepatotoxicity. Sevoflurane is the preferred agent for mask induction due to its lesser irritation to mucous membranes.

Sevoflurane was discovered by Ross Terrel and independently by Bernard M Regan. A detailed report of its development and properties appeared in 1975 in a paper authored by Richard Wallin, Bernard Regan, Martha Napoli and Ivan Stern. It was introduced into clinical practice initially in Japan in 1990 by Maruishi Pharmaceutical Co., Ltd. Osaka, Japan. The rights for sevoflurane worldwide were held by AbbVie. It is now available as a generic drug.

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. you don't mind ask with us if your nation or district isn't recorded:

ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Australia, New Zealand, Fiji, and so forth.

Accurate Anesthesia Delivery

The Sevoflurane Vaporizer is engineered to deliver precise concentrations of sevoflurane, as needed for anesthesia in adult patients. Its advanced design ensures accurate dosing, significantly enhancing patient safety during surgical procedures. Healthcare professionals rely on its consistency and efficiency to maintain a stable anesthetic depth throughout the operation.

Robust Packaging and Storage

Every vaporizer is distributed in secure 250 ml bottles, ensuring convenience and safety in handling and usage. The packaging is designed to maintain product integrity, and the vaporizer should be stored in a cool, dry location to preserve its efficacy for longer periods.

FAQ's of Sevoflurane Vaporizer:

Q: How does the Sevoflurane Vaporizer ensure accurate delivery of anesthesia?

A: The vaporizer is engineered to deliver precise concentrations of sevoflurane, typically between 0% and 8%. This allows anesthesiologists to control the depth of anesthesia effectively during medical procedures, enhancing patient safety.

Q: What is the recommended process for using the Sevoflurane Vaporizer?

A: Usage should always be as directed by a physician. The vaporizer is filled with liquid sevoflurane and attached to an anesthetic machine, which then delivers measured doses to patients during surgeries or procedures.

Q: When should the Sevoflurane Vaporizer be utilized?

A: It should be used whenever inhalational anesthesia with sevoflurane is required in adults, commonly during surgeries or other medical interventions that necessitate general anesthesia.

Q: Where should the vaporizer be stored between uses?

A: For optimal performance and stability, store the vaporizer in a cool and dry place, away from direct sunlight and high humidity, as recommended for medical-grade equipment.

Q: What are the benefits of using this specific vaporizer for sevoflurane administration?

A: This vaporizer offers reliable, consistent delivery of sevoflurane, reducing the risk of dosage errors. It enhances the safety and efficiency of anesthesia management in medical settings.

Q: How is the Sevoflurane Vaporizer packaged for distribution?

A: Each vaporizer unit comes in a 250 ml bottle and is securely packaged to ensure it arrives intact and ready for use. The product is available through wholesalers, distributors, and suppliers across India.